Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Region Hovedstadens forskningsportal Forside
Hjælp og OSS
Dansk
English
Forside
Hospitaler/afdelinger
Forskere
Publikationer
Aktiviteter
Priser
Søg efter ekspertise, navn eller tilknytning
Exenatide and liraglutide: different approaches to develop GLP-1 receptor agonists (incretin mimetics)--preclinical and clinical results
Sten Madsbad
Endokrinologisk Afdeling
123
Citationer (Scopus)
Oversigt
Fingeraftryk
Fingeraftryk
Dyk ned i forskningsemnerne om 'Exenatide and liraglutide: different approaches to develop GLP-1 receptor agonists (incretin mimetics)--preclinical and clinical results'. Sammen danner de et unikt fingeraftryk.
Sorter
Vægt
Alfabetisk
Keyphrases
A1 Receptor
100%
Receptor Agonist
100%
Glucagon-like
100%
Liraglutide
100%
Exenatide
100%
Incretin Mimetics
100%
Hemoglobin A1c (HbA1c)
40%
Treatment Algorithm
20%
Adverse Effects
20%
Type 2 Diabetes Mellitus (T2DM)
20%
Once-daily
20%
Glycemic Control
20%
Nausea
20%
Fasting Plasma Glucose
20%
Weight Loss
20%
Gastric Emptying
20%
Insulin Secretion
20%
Vomiting
20%
Glucagon
20%
Diabetes Management
20%
Gastrointestinal Side Effects
20%
Pharmacology, Toxicology and Pharmaceutical Science
Liraglutide
100%
Glucagon Like Peptide 1 Receptor Agonist
100%
Exendin 4
100%
Incretin
100%
Hemoglobin A1c
50%
Adverse Event
25%
Non Insulin Dependent Diabetes Mellitus
25%
Nausea and Vomiting
25%
Glucagon
25%
Glucagon-Like Peptide-1
25%
Gastrointestinal Symptom
25%